These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30611093)

  • 21. Cerebral Microbleeds in Patients with Parkinson's Disease and Dementia with Lewy Bodies: Comparison Using Magnetic Resonance Imaging and 99 mTc-ECD SPECT Subtraction Imaging.
    Takemoto M; Yamashita T; Ohta Y; Tadokoro K; Omote Y; Morihara R; Abe K
    J Alzheimers Dis; 2021; 80(1):331-335. PubMed ID: 33523013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic.
    Kondo D; Ota K; Kasanuki K; Fujishiro H; Chiba Y; Murayama N; Sato K; Hirayasu Y; Arai H; Iseki E
    J Neurol Sci; 2016 Oct; 369():102-108. PubMed ID: 27653873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography.
    Koeppe RA; Gilman S; Junck L; Wernette K; Frey KA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S67-76. PubMed ID: 18632004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
    Fujishiro H; Iseki E; Murayama N; Yamamoto R; Higashi S; Kasanuki K; Suzuki M; Arai H; Sato K
    Psychogeriatrics; 2010 Sep; 10(3):144-52. PubMed ID: 20860570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower
    Joling M; Vriend C; van der Zande JJ; Lemstra AW; van den Heuvel OA; Booij J; Berendse HW
    Neuroimage Clin; 2018; 19():130-136. PubMed ID: 30035010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain amyloid and cognition in Lewy body diseases.
    Gomperts SN; Locascio JJ; Marquie M; Santarlasci AL; Rentz DM; Maye J; Johnson KA; Growdon JH
    Mov Disord; 2012 Jul; 27(8):965-73. PubMed ID: 22693110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interrelation of striatal dopamine, brain metabolism and cognition in dementia with Lewy bodies.
    Yoo HS; Jeong SH; Oh KT; Lee S; Sohn YH; Ye BS; Yun M; Lee PH
    Brain; 2022 Dec; 145(12):4448-4458. PubMed ID: 35234856
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Smith R; Schöll M; Londos E; Ohlsson T; Hansson O
    Sci Rep; 2018 Mar; 8(1):4717. PubMed ID: 29549278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three presenile patients in which neuropsychological and neuroimaging examinations suggest possible progression to dementia with Lewy bodies.
    Ota K; Iseki E; Murayama N; Chiba Y; Fujishiro H; Kasanuki K; Manabe Y; Arai H; Sato K
    Psychogeriatrics; 2014 Mar; 14(1):72-80. PubMed ID: 24528622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
    Iranzo A; Santamaría J; Valldeoriola F; Serradell M; Salamero M; Gaig C; Niñerola-Baizán A; Sánchez-Valle R; Lladó A; De Marzi R; Stefani A; Seppi K; Pavia J; Högl B; Poewe W; Tolosa E; Lomeña F
    Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
    Walker Z; Costa DC; Walker RW; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona CL
    Neurology; 2004 May; 62(9):1568-72. PubMed ID: 15136683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S; Kanetaka H; Hirao K; Fukasawa R; Namioka N; Hatanaka H; Hirose D; Umahara T; Sakurai H; Hanyu H
    Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A follow up study of non-demented patients with primary visual cortical hypometabolism: prodromal dementia with Lewy bodies.
    Fujishiro H; Iseki E; Kasanuki K; Chiba Y; Ota K; Murayama N; Sato K
    J Neurol Sci; 2013 Nov; 334(1-2):48-54. PubMed ID: 23927939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temporal Variation in Disease Onset and Clinical Features of Lewy Body Disease in China.
    Gan J; Chen Z; Shi Z; Li X; Liu S; Liu Y; Zhu H; Shen L; Zhang G; You Y; Guo Q; Zhang N; Lv Y; Gang B; Yuan J; Ji Y
    J Alzheimers Dis; 2022; 90(3):1263-1275. PubMed ID: 36245379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.
    Colloby SJ; O'Brien JT; Fenwick JD; Firbank MJ; Burn DJ; McKeith IG; Williams ED
    Neuroimage; 2004 Nov; 23(3):956-66. PubMed ID: 15528096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD).
    Nobili F; Morbelli S; Arnaldi D; Ferrara M; Campus C; Brugnolo A; Mazzei D; Mehrdad N; Sambuceti G; Rodriguez G
    J Neurol Sci; 2011 Nov; 310(1-2):31-5. PubMed ID: 21762928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
    Yong SW; Yoon JK; An YS; Lee PH
    Eur J Neurol; 2007 Dec; 14(12):1357-62. PubMed ID: 17941855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
    Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
    Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.